ALZAI is an AI platform that identifies Alzheimer’s and cognitive aging risk years before symptoms appear.
No invasive exams
No scans
No friction
We analyze routine health data – basic labs and demographics – to find early cognitive risk signals and turn them into actionable risk scores.
Built to Plug In, Not Slow You Down
ALZAI integrates directly into your existing longevity stack, so you can add cognitive risk screening without rebuilding your product.
It’s Simple:
Connect:
API or secure portal
Screen:
AI analyzes existing user health data
Deliver:
Risk insight returned to your platform
How ALZAI Unlocks the Longevity Stack
Increase Engagement
Give users meaningful insight into their future brain health, beyond dashboards.
New Revenue
Offer cognitive risk screening as a premium feature or add-on, upsell related products.
Deepen Personalization
Guide smarter prevention, coaching, and longevity pathways.
Differentiate Your Platform
Most longevity products track biomarkers. Few address true cognitive risk early.
Flexible by Design
ALZAI is designed to scale with you.
One-time integration
Per-user screening model
Volume-based pricing
We work with partners to find the right commercial fit.
Built on Real-World Data
ALZAI’s models are trained and validated on large-scale real-world health data; designed for population-level screening and long-term impact for use in clinical trials.
This is not a concept. It’s infrastructure.
Bring Cognitive Risk Into Your Longevity Offering
If you’re building the future of longevity, cognitive health can’t be an afterthought.